5-Bromoisatin → 5-Bromo-3-hydroxy-3-prop-1-ynyl-1,3-dihydroindol-2-one

HRID 6991

반응식

HRID 6991 반응식
[Br:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][C:6](=[O:11])[C:5]2=[O:12].[C:13]([Mg]Br)#[C:14][CH3:15].[Cl-].[NH4+]>C1COCC1>[Br:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][C:6](=[O:11])[C:5]2([OH:12])[C:13]#[C:14][CH3:15]

참가 물질

5

반응물 3

HCID 68895-BromoisatinHCID 25517Ammonium ChlorideHCID 178419101HCID 178419101, 화합물

생성물 1

HCID 120859385-Bromo-3-hydroxy-3-prop-1-ynyl-1,3-dihydroindol-2-one수율 97%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매

실험 절차

To a solution of 5-bromoisatin (2.5 g, 11 mmol) in dry THF (100 cm3) at −10° C. under a nitrogen atmosphere was added 1-propynylmagnesium bromide (0.5 M in THF, 47 cm3, 23.5 mmol). After 1 h, the mixture was poured into saturated ammonium chloride and extracted with EtOAc (×3), washed with brine, dried (MgSO4) and evaporated to afford 5-bromo-3-hydroxy-3-prop-1-ynyl-1,3-dihydroindol-2-one (2.83 g, 10.6 mmol, 97%) which was used without further purification: (CDCl3) δ 1.83 (s, 3H), 6.79 (d, 1H, J=8.0 Hz), 6.90 (s, 1H), 7.41–7.44 (m, 2H), 10.59 (s, 1H); MS ((−) ESI) m/z 264 (M−H)−.

후처리

  1. extractionextracted with EtOAc (×3)
  2. washwashed with brine
  3. dry with materialdried (MgSO4)
  4. customevaporated

출처 및 근거

ORD 기록
ord-11c8f6a6d49c4e53ba77cc33793f0bd3
출처 데이터셋
uspto-grants-2006_08
특허 번호
US07084168B2

연결된 노트

불러오는 중…